Tag Archives: Research

New event introduces third-year students to medical research

Faculty members judged the student teams’ research posters.

On Dec. 5, more than 100 third-year medical students presented research findings at the UMKC School of Medicine as part of their coursework in medical neuroscience.

Students, in teams of four, used data from the Cerner HealthFacts database to try to answer a unique question they identified related to various disease and conditions. Those examined included Alzheimer’s Disease, stroke, obsessive-compulsive disorder, epilepsy and diabetes. After analyzing the data and drawing conclusions, each team made a poster displaying its question and hypothesis, telling how the team members went about testing their hypothesis, explaining their findings, and identifying questions for further study.

The idea behind the exercise was to give students an early research experience, and for many it was their first medical research.

By all accounts, the assignment was a success. Several students said that before the exercise they were worried about how difficult it would be to do research, but now they looked forward to being able to do more.

Shafaa Mansoor, whose team studied possible seasonal effects on strokes, said she is interested in community health and now sees research as a way to further that interest, identify the real effects of medical conditions and test possible treatments.

Her teammates Rebecca Kurian and Tom Matthews agreed that the project was a good, hands-on way to learn how to do research.

“The process was as important as the results,” Matthews said. “Learning how to do this and present our findings was valuable.”

More than 40 faculty members collaborated to make the project a reality, including several who judged the presentations. Each team also had a faculty mentor and a supporting biostatistician from the Department of Biomedical & Health Informatics, Children’s Mercy Hospital or the School of Nursing and Health Studies.

One of the judges, Maria Cole, M.Ed.L., Ph.D., an associate professor in biomedical sciences, very much liked what she saw.

“I had these students in class in January and it’s something to see how far they have come since then,” she said. “Their ability to analyze data and explain their findings, and to link their results to what they learned in class, is impressive.”

Jennifer Bickel (second from left), M.D. ’01, associate professor of pediatrics and chief of the headache section at Children’s Mercy Hospital; was one of three faculty members who devised the exercise. She circulated among the student research teams to get their thoughts on the exercise.

The exercise was devised by Jennifer Bickel, M.D. ’01, associate professor of pediatrics and chief of the headache section at Children’s Mercy Hospital; Julie Banderas, Pharm.D., BCPS, professor and interim chair of the Department of Biomedical & Health Informatics, professor and associate dean for graduate studies; and Paula Monaghan-Nichols, Ph.D., professor and chair of the Department of Biomedical Sciences and associate dean for research.

“There was no model for this, so we’re learning as we go,” said Bickel, who talked with the teams about their experiences. “We will make improvements and hope this is something we can eventually share with other programs. It’s exciting to be doing something completely new.”

The teams were judged for poster content, clarity, appearance and organization; their oral presentations; and demonstration of critical thinking.

The top three teams were announced Dec. 6:

First place: Jonathan Jalali, Chidera Okafor, Jacob Perera and Amudha Porchezhian, “Is Patient Sex Linked to Pharmacologic Agents that Induce Acute Dystonic Reaction?”

Second place: Caleb Spencer, Grace Arias, Debolina Kanjilal and Kyla Mahone, “Correlation Between Elevation in Inflammatory Markers of ESR and CRP in Patients Diagnosed with OCD and OCPD and Age.”

Third place: Saniya Ablatt, Vijaya Dasari, Gauri Kaushal and Andrea Pelate, “Stroke Incidence at a Young Age in Rural vs. Urban Populations.”

 

 

Surgical Innovations Lab puts patient safety at the forefront

Gary Sutkin, M.D., has established the School of Medicine’s Surgical Innovations Laboratory.

At the UMKC School of Medicine’s Surgical Innovations Laboratory, Gary Sutkin, M.D., professor of surgery and associate dean for women’s health, is taking a different approach to research.

As director of the lab, Sutkin, who also serves as the Victor and Caroline Shutte Endowed Chair in Women’s Health, has gathered an interdisciplinary team to look at ways to make surgical procedures safer for patients.

Inside the “Surgilab” — his third-floor “think tank” —  one can find a pair of large bean bag chairs sitting in a corner on a colorful rug. A portion of one wall is filled with large-screen video monitors. A rectangular conference table in front of the wall is surrounded by different colored chairs. This is all by design, Sutkin explains.

“It’s all about creativity,” he said. “The chairs being different colors represent different ideas that people bring forth. It wasn’t just convenience. The people we work with come from different backgrounds.”

Gary Sutkin, M.D., leads an interdisciplinary team that is exploring ways to make surgical procedures safer for patients.

Biomedical engineers, mechanical engineers, and even a theater instructor, gather to discuss surgical procedures and how the operating room team of nurses and technicians can more effectively work together. They do this through studying practitioners’ movements and non-verbal communications.

“We’re one big community here, trying to make surgery safer for patients,” Sutkin said. “We’re trying to make it safer by cutting down on errors and improving communication. The operating room is such a fast-paced, high-risk environment. You have all these people from different backgrounds trying to work together, all with the same goal to have an effective, safe surgery. But they have to communicate well to do that.”

Physicians learn to do better by talking about the mistakes that take place during surgical procedures. One of Sutkin’s projects involves interviewing a number of surgeons to get their perspectives on surgical errors and how to prevent them. It’s a topic that he says surgeons think about often and are quite open to talking about with colleagues.

“I’ve told my mistake stories over and over,” Sutkin said. “It’s only by putting them out in the open and talking about them that we can learn from them and fix our ways.”

The work of the Surgilab is supported by a grant from the University of Missouri Review Board and funding from Sutkin’s endowed chair appointment.

With his research assistant, Fizza Mahmud, and a cohort of interdisciplinary colleagues, Sutkin and company are also exploring the process involved in Midurethral Sling Surgery. The procedure is a minimally invasive approach to treating a common urinary problem of incontinence in women. But it also involves surgical risks.

During a work session, Sutkin grabs a handful of playdoh and begins to form a shape to help describe to the non-medical members of his team the female anatomy and how the surgical instruments are used during the procedure.

“Human error is a part of any high-risk industry,” Sutkin said. “Whether it’s aviation, the railway industry, or surgery, it’s going to happen. You’re never going to get it down to zero, but you’re always trying to make it lower and lower.”

Research office announces eight Sarah Morrison Award recipients

October 2017 Sarah Morrison student research award recipients:
Jonah Graves, Jonathan Jalali, Kelly Kapp, Landon Rohowetz, Subhjit Sekhon, Mehr Zahra Shah, Yevgeniy Khariton and Krishna Patel.

The School of Medicine Student Research Program has announced six medical students and two students from the biomedical and health informatics program as recipients of the Fall 2017 Sarah Morrison Student Research Award.

The awards support student research efforts and help fund presentations at conferences and scientific meetings.

Medical students who received the awards are Jonah Graves, fifth-year; Jonathan Jalali, third-year; Kelly Kapp, sixth-year; Landon Rohowetz, fourth-year; Subhjit Sekhon, fifth-year; and Mehr Zahra Shah, fourth-year. Two recipients, Yevgeniy Khartion and Krishna Patel, are graduate students in the school’s Department of Biomedical and Health Informatics.

Sarah Morrison awards of up to $2,500 are presented each year in October and April. More than 100 students have received an estimated $104,669 in financial support from the program to conduct research projects at the School of Medicine.

Students interested in the Sarah Morrison awards are encouraged to apply prior to the April 1 and Oct. 1 deadlines each year. Applicants are reviewed by a committee of faculty judges and processed through the Office of Research Administration.

For complete application information, visit the student research website.

Fall 2017 Sarah Morrison Research Awards
(Recipients, Project titles, Mentors)
  • Jonah Graves, MS 5, Mechanism for FGF23 induced mechanical alternans in mouse hearts, Mike Wacker
  • Jonathan Jalali, MS 3, Retinal blood vessel morphometry as a biomarker for progression of diabetic retinopathy to diabetic macular edema and neovascular complications, Peter Koulen
  • Kelly Kapp, MS 6, Glycocalyx Production by Viridans Streptococci Causing Endocarditis: Assessment of the Tryptophan Assay as a Marker to Predict Disease, Lawrence Dall
  • Landon Rohowetz, MS 4, The role of innate immune system signaling pathways in age-related macular degeneration pathogenesis, Peter Koulen
  • Subhjit Sekhon, MS 5, Identification of Gene Expression, Ferdaus Hassan
  • Mehr Zahra Shah, MS 4, The role of estrogen hormone signaling pathways in glaucoma pathogenesis, Peter Koulen
  • Yevgeniy Khartion, DBHI, Patterns of Intravenous Fluid and Diuretic Co-Administration in Acute De-Compensated Heart Failure: Insights from the Health Facts Registry, John Spertus
  • Krishna Patel, DBHI, Imaging findings associated with potential survival benefit with early revascularization in patients undergoing stress myocardial perfusion imaging using Positron emission Tomography for suspected coronary ischemia, Timothy Bateman

New research fellowship explores pediatric headache treatment

Dane Stephens, Subhjit Sekhon

Two students at the UMKC School of Medicine have received a new award from the Children’s Mercy Hospital Philanthropy Fund to support research interests in neurology.

Dane Stephens, a fourth-year student, and Subhjit Sekhon, a fifth-year student, are the first recipients of the Neurology Research and Scholar Award. The award is given to students who will work on research projects with the Headache Research Group in the Division of Neurology at Children’s Mercy Kansas City.

Award recipients will work closely with the research group to design, implement and present research findings in the area of pediatric headache assessment and management. Research fellows also attend the American Academy of Neurology annual conference. There they will network with other professionals in the field, and attend presentations and poster displays, as well as other pertinent educational opportunities.

Research projects, while focused on headache treatment, vary based on current studies being conducted at any given time within the group.

The research fellowship award is available to qualified fourth, fifth or sixth-year B.A./M.D. students or second, third or fourth-year M.D. students at the UMKC School of Medicine. Students must commit to at least 80 total research hours throughout a 12-month period. A medical school research elective with the Children’s Mercy Hospital Department of Neurology is highly encouraged.

Jennifer Bickel, M.D., associate professor of pediatrics and chief of the headache section at Children’s Mercy, will serve as faculty mentor for the research projects.

The Headache Research Group is comprised of physicians, nurse practitioners and additional allied health professionals. Bickel leads the interdisciplinary team in its commitment to improving education, advocacy and research regarding headache care in children.

Stephens and Sekhon are part of a fast growing number of students actively taking part in research activities. Below is a list of some School of Medicine students who have recently been selected for summer and yearlong research fellowships and been invited to present their research at regional and national meetings.

Year-long Fellowships:
Grant Randall, NIH Medical Research Scholars Program
Sultan Khan, TL1 Predoctoral Clinical Research Training Program, Washington University
Carlee Oakley, TL1 Clinical Research Training Program, University of Kansas Medical Center
Dane Stephens, Subhjit Sekhon, Neurology Research and Scholar Award, Headache Research Group in the Division of Neurology at Children’s Mercy Kansas City

Summer Fellowships:
Akash Jani, George Washington University Summer Research Internship, Dept. of Emergency Medicine
Vishnu Harikumar, Pediatric Oncology Education Program, St. Jude Children’s Research Hospital
Priyesha Bijlani, Washington University Pediatric Student Research Program
Elizabeth George, Unite for Sight Summer Program in India
Ashwath Kumar, Health Policy Fellowship Initiative (American Academy of Ophthalmology, Washington, D.C.
Ben Bernard*, NIDDK Medical Student Research Training Program in Diabetes, Obesity, and Metabolic Disorders (*had to decline due to another research opportunity in Israel)
Chizitam Ibezim*, NIH Summer Internship Program (*had to decline due to other obligations)

Selected to present research at regional or national meetings:
Sarah Alshami, International Facial Nerve Symposium, Los Angeles, CA, August 2017
Noor Alshami, American Academy of Pediatrics, Chicago, IL, September 2017
Morgan Warren, Central Association of OB/GYN, Scottsdale, AZ, October 2017
Sumita Sharma, American Academy of Physical Medicine and Rehabilitation, Denver, CO, October 2017
Suzan Lisenby, American Academy of Physical Medicine and Rehabilitation, Denver, CO, October 2017
Siri Ancha, World Congress of Gastroenterology, Orlando, FL, October 2017
Ravali Gummi and Imran Nizamuddin, Clinton Global Initiative, Boston, MA, October 2017
Chizitam Ibezim, AHA Scientific Sessions, Anaheim, CA, November 2017
Amber (Leila) Sarvastani, AHA Scientific Sessions, Anaheim, CA, November 2017
Hunter Faris, AMA, Honolulu, HI, November 2017
Vaishnavi Vaidyanathan, Child Neurology Society Annual Meeting, Kansas City, MO, October 2017

UMKC researchers to present late-breaking studies at cardiovascular symposium

Research studies by UMKC School of Medicine faculty researchers at the Saint Luke’s Mid America Heart Institute have been selected for presentation at the world’s largest educational meeting for interventional cardiovascular medicine.

The researchers are the first or senior authors of 10 original studies and contributing authors of nine other studies selected for presentation at the 2017 Transcatheter Cardiovascular Therapeutics symposium in Denver, running October 30 through November 2.

The presentations includes two major studies selected as Late-Breaking Clinical Trials. Only 12 research breakthroughs highlighting the most innovative treatments for heart disease are selected for the late-breaking presentations.

“It is rare for any institution to have even one late-breaking trial presentation at a major cardiology meeting,” said David Cohen, M.D., professor of medicine and MAHI director of cardiovascular research. “Having two of the 12 come from the Mid America Heart Institute is an incredible honor and a testimony to both the Mid America Heart Institute Clinical Scholars program and the international reputation that our research program has come to enjoy.”

Suzanne Baron, M.D., assistant professor of medicine, is the lead author of a study that describes the long-term quality of life outcomes of nearly 2,000 patients enrolled in a landmark multi-center trial. The research compared everolimus-eluting stents and bypass surgery for the treatment of left main coronary artery disease. Cohen is the lead author of the second study that evaluates the cost effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in intermediate risk patients.

Four of the MAHI studies to be presented at this year’s meeting are the direct result of a groundbreaking OPEN-Chronic Total Occlusions (CTO) registry. The registry is led by Aaron Grantham, M.D., associate professor of medicine, with assistants from  Adam Salisbury, M.D., assistant professor of medicine, and the support of the MAHI Outcomes Research group. The studies define the success, safety, health benefits and cost effectiveness of novel techniques to open blocked coronary arteries that are considered untreatable through minimally invasive techniques.

Brain tumor research follows unusual path

Tom Curran, Ph.D.

A promising therapy to combat brain tumors in children has emerged from a confluence of bold research, scientific insight and luck, a Children’s Mercy research director said Aug. 30 in the latest installment in the UMKC Health Sciences Deans’ Seminar Series.

The research aims to block a pathway that mutant cells often take when forming tumors near the brain stem. The work’s progress and hurdles were detailed by Tom Curran, Ph.D., who is the executive director and chief scientific officer of the Children’s Research Institute and a professor of pediatrics at the UMKC School of Medicine.

His presentation was titled “How mice, sheep, corn lilies and a beer helped children with brain tumors: Targeting the hedgehog pathway in medulloblastoma.”

When he started the hedgehog inhibitor work, Curran already had contributed extensively to the understanding of tumor formation – and knew plenty about mice. He discovered the Fos-Jun tumor-generating complex, and had identified reelin, the gene responsible for reeler, the mutation that makes mice lose muscle control.

Curran wanted to extend his mutation research to the tumors that form during brain development, “so we made the decision that we would take a take a precision medicine approach to medulloblastoma, even though we knew nothing about it at the time.”

He said his team came up with “a very naive concept” for proceeding: to identify molecules involved in tumor formation and then develop inhibitors for them, confirming both the mutations and their inhibition in mouse studies. After cause and prevention were demonstrated in mice, clinical drug trials in humans would follow.

The plan, however naive, has generated significant research success.

“That’s what translational research is about,” he said. “You have to develop a simple model … with milestones that let you know you’re making progress toward the goals.

“The other factor that is really important to this kind of science is luck. You need to be in the right place at the right time.”

The project’s first indication of good timing came quickly.

“Three weeks after we decided we were going to target medulloblastoma, the very first paper came out linking the sonic hedgehog pathway and … these tumors.” (A family of mutant genes with a spiky appearance is called hedgehog genes, and one of those was named after the Sonic Hedgehog computer game a Harvard researcher’s son was fond of.)

Sheep and corn lilies entered the picture when Curran was looking for a hedgehog-path inhibitor to work with and recalled a story about sheep giving birth to one-eyed lambs. What might have been a genetic defect was determined instead to be caused by a chemical in the corn lilies the ewes had eaten. The chemical, named cyclopamine, was found to block the sonic hedgehog path, the effect Curran was looking for. But it also was toxic and eventually seemed unlikely to lead to a suitable drug for humans.

Fortune intervened again when Curran was having a beer with a colleague after a conference in Taos, N.M. The friend was an expert on the sonic hedgehog pathway and referred Curran to another researcher whose team was doing similar work but running out of money for testing. Curran got in touch with the other team and was able to do the testing, which produced good results.

The project also has had its share of challenges to overcome, including recurrence of tumors after initial success in a human trial. That often happens in cancer treatment, Curran said, as drug resistance develops. But a biopsy from that case has provided further information, and trials continue.

Besides his positions at the Children’s Research Institute and UMKC, Curran is the Donald J. Hall Eminent Scholar in Pediatric Research and a professor of cancer biology at the University of Kansas School of Medicine.

Before coming to Kansas City, he led the Translational Brain Tumor Program for a decade at St. Jude Children’s Research Hospital; was deputy scientific director of the Children’s Hospital of Philadelphia Research Institute for another decade; and set up the multi-institution Children’s Brain Tumor Tissue Consortium.

Curran earned his doctorate for studies at the Imperial Cancer Research Fund Laboratories in London. His work has been published in nearly 300 papers and cited more than 50,000 times.

 

 

 

Faris receives UMKC Project ADVANCER award

Third-year medical student Hunter Faris, left, has received a research award to work with John Q. Wang, M.D., Ph.D., Westport Anesthesia/Missouri Endowed Chair in Anesthesia Research.

Third-year medical student Hunter Faris has been selected for a student research award from the UMKC strategic funding award initiative, Project ADVANCER (Academic Development Via Applied aNd Cutting-Edge Research). The program supports research projects of UMKC undergraduate and professional students from underrepresented minorities.

Faris will be working with faculty mentor, John Q. Wang, M.D., Ph.D., Westport Anesthesia/Missouri Endowed Chair in Anesthesia Research, to establish a previously unrecognized mechanism underlying the regulation of neuronal activities. His project, Regulation of Src Family Protein Kinases in the Rat Striatum by Muscarinic Acetylcholine Receptor, could significantly advance the knowledge of receptor signaling and protein kinases biology.

Project ADVANCER is a UMKC initiative to provide students the opportunity to gain experience and build a “track record” in research. That experience will provide students better access to competitive postgraduate training such as residencies or graduate programs and, ultimately, to better employment opportunities.

Students who have identified a UMKC faculty mentor in the College of Arts and Sciences, Department of Geosciences; School of Biological Sciences; School of Computing and Engineering; School of Medicine; or School of Nursing and Health Studies may jointly develop an application for a Project ADVANCER award with their faculty mentor.

Faris and Wang expect to produce results that will be published in a peer-reviewed scientific journal.

Med School scientist receives American Heart Association grant for research study

Mingui Fu, Ph.D.

The American Heart Association has awarded a $154,000 grant to UMKC School of Medicine scientist Mingui Fu, Ph.D., to conduct a two-pronged study that could lead to the development of novel therapies for vascular inflammatory diseases.

An associate professor in the Department of Biomedical Science, Fu has been studying the molecular process that leads to atherosclerosis, a thickening of the artery walls created by the buildup of plaque. Atherosclerosis is a common underlying issue surrounding cardiovascular disease and stroke.

While some therapies have proven beneficial, there are currently no available treatments to reduce the early steps that lead to the formation of these abnormal arterial masses.

Fu’s new study will explore at a molecular level the process by which a particular protein, TRIM65, has been found to target those molecules responsible for regulating inflammation, antivirus and cancers. The research also seeks to determine how the loss of the TRIM65 protein affects the adhesion of those abnormal fatty cells to arterial walls to produce atherosclerosis.

If successful, Fu’s study will define a regulatory pathway of endothelial activation and provide insights for developing new therapies for vascular inflammatory diseases such as atherosclerosis.

Recently, Fu and his research lab at the School of Medicine published a paper in the journal Scientific Reports that revealed the discovery of a novel secreted protein in body fat tissue that displayed a potent anti-inflammatory role in immune cells and vascular endothelial cells. In addition, he also has published a review article in Nature Reviews Immunology about RNA-binding proteins in immune regulation.

According to a 2017 report by the American Heart Association, cardiovascular disease is the worldwide leading cause of death and is an underlying factor in nearly one-third of all deaths in the United States.

Donors set sights on work at Vision Research Center

Situated prominently on the corner of 21st and Charlotte is UMKC School of Medicine’s Department of Ophthalmology and Vision Research Center, a bustling center of excellence within the new UMKC Health Sciences District. Yet, even with the cutting-edge research and advanced academics taking place under its roof, many are unaware of the critical position it plays in improving the treatment of eye disease for people in our community and beyond.

Nelson Sabates, M.D., professor and chairman of the Department of Ophthalmology and co-director of the Vision Research Center, is working to heighten the facility’s recognition and its continued efforts to offer the most advanced academic environment for teaching the next generation of ophthalmologists.

Two recent gifts from donors, one from the estate of Mary Adams and the other from an anonymous contributor, are helping to make this goal possible by supporting basic science research being conducted by UMKC faculty members, Peter Koulen, Ph.D., and Karl Kador, Ph.D.

“These gifts will have a significant impact on our ability to provide newer and longer lasting treatments for patients diagnosed with glaucoma, macular degeneration and diabetic retinopathy,” Sabates. “We are grateful to have been chosen by these donors as the recipients of their generous contributions to our mission of ensuring patients receive the most advanced medical treatments available.”

Both researchers are working to develop new therapy approaches urgently needed by physicians worldwide to better diagnose, prevent, and treat eye disease and vision disorders.

Koulen, the Felix and Carmen Sabates Missouri Endowed Chair in Vision Research and Director of Basic Research at the Vision Research Center, focuses on therapy development for chronic diseases of the eye and brain. Kador’s research focuses on creating three-dimensional models of the retina that can be used to understand how retinal ganglion cells (RGCs) integrate and form synapses (the point at which a nervous impulse passes from one neuron to another) with their binding partners within the retina. He and his lab are working to develop a functional cell source and transplantation method to treat optic neuropathies such as glaucoma and optic nerve stroke.

“Having an endowed chair in vision research has been instrumental in our ability to conduct research at UMKC and, in order to continue moving forward, we need to raise additional funds for a second endowed chair,” Sabates said.

Sabates will join the UMKC Foundation Board of Directors in July and is resolute in seeing a new health sciences building become a reality.

“I, along with many others, am a true advocate for advancing UMKC’s combined health sciences with a modern, functional space where faculty and students can have access to the latest technologies,” he said. “I am excited to be a voice for the health sciences arena at UMKC.”

Built on a 50-year history, UMKC’s Department of Ophthalmology and the Vision Research Center look to opportunities for future growth in research, education, prevention, treatment and outreach.

Sarah Morrison research award winners announced

Recipients of the April 2017 Sarah Morrison student research awards are (left to right) Jessica Kieu, Shipra Singh, Vishal Thumar, Komal Kumar, and Katherine Suman.

Five School of Medicine’s students have been selected by the Student Research Program to receive Sarah Morrison Student Research Awards. The awards  support support research efforts and help students fund their presentations at conferences and scientific meetings.

The April 2017 recipients are Jessica Kieu, fourth-year medical student, Komal Kumar, fourth-year medical student, Shipra Singh, fourth-year medical student, Katherine Suman, sixth-year medical student, and Vishal Thumar, sixth-year medical student.

Sarah Morrison award recipients are reviewed by a committee of faculty judges and processed through the school’s Office of Research Administration. Awards of up to $1,500 are presented each April and October. Since 2013, students have received more than $61,000 in financial support from the Sarah Morrison program to support research projects at the School of Medicine.

Students interested in the Sarah Morrison Research awards are encouraged to apply prior to the April 1 and Oct. 1 deadlines each year. For complete application information, visit the Office of Research Administration’s student research website.

Award winners, abstract titles and faculty mentors

  • Jessica Kieu, “Maternal-fetal reactions to acute emotional stress in prenatal depressed mothers: correlations with fetal biomagnetometry measures,” Prakash Chandra – TMC
  • Komal Kumar, “Pregnant Women with Previous Mental Health Disorders and Behavior During Ultrasound,” Prakash Chandra – TMC
  • Shipra Singh, “The Effect of NAAA Gene Expression on Acetaminophen Hepatotoxicity,” Shui Ye – CMH
  • Katherine Suman, “The role of innate immune system signaling pathways in glaucoma pathogenesis,” Peter Koulen – Vision Research Center
  • Vishal Thumar, “Visualizing the Difference between Life and Death: A Comparison of Liver Ultrasound Findings in Children with Sinusoidal Obstruction Syndrome After Bone Marrow Transplantation,” Sherwin Chan – CMH